<PAGE>1


                                        August 28, 1997






          Securities & Exchange Commission
          Judiciary Plaza
          450 Fifth Street, N.W.
          Washington, D.C.  20549

               Re:  Gerber Scientific, Inc.
                    Commission File No. 1-5865

          Gentlemen:

          Pursuant   to  regulations   of  the   Securities  and   Exchange
          Commission,  submitted herewith  for filing  on behalf  of Gerber
          Scientific, Inc. (the  "Company") is the Company's  Form 10-Q for
          the quarter ended July 31, 1997.

          This  filing is  being  effected by  direct  transmission to  the
          Commission's EDGAR System.

                                        Very truly yours,
 

                                        /s/ Gary K. Bennett
                                        Senior Vice President, Finance
                                        and Principal Financial Officer

<PAGE>2


                    UNITED STATES SECURITIES AND EXCHANGE COMMISSION

                                 WASHINGTON, D.C.  20549


                                        FORM 10-Q

               (MARK ONE) QUARTERLY REPORT / X / OR TRANSITION REPORT /  /
                           PURSUANT TO SECTION 13 OR 15(d) OF
                           THE SECURITIES EXCHANGE ACT OF 1934



        For the quarter ended
            July 31, 1997                             Commission File No. 1-5865



                                GERBER SCIENTIFIC, INC.               
                ------------------------------------------------------
                 (Exact name of Registrant as specified in its charter)




                  CONNECTICUT                                   06-0640743     
        -------------------------------                     -------------------
        (State or other jurisdiction of                       (I.R.S. Employer
        incorporation or organization)                      Identification No.)



          83 Gerber Road West, South Windsor, Connecticut             06074  
        --------------------------------------------------         ----------   

              (Address of principal executive offices)             (Zip Code)



        Registrant's Telephone Number, including area code       (860) 644-1551 
                                                                ----------------

        Indicate by check mark whether the registrant  (1) has filed all reports
        required to be  filed by Section 13 or 15(d)  of the Securities Exchange
        Act of 1934 during the  preceding 12 months (or for such  shorter period
        that the registrant was required to file such reports) and  (2) has been
        subject to such filing requirements for the past 90 days.


                                Yes  / X / .   No /  / .


        At July  31, 1997, 23,347,275 shares  of common stock of  the Registrant
        were outstanding.

<PAGE>3

                                 GERBER SCIENTIFIC, INC.
                                    AND SUBSIDIARIES

                        CONTENTS OF QUARTERLY REPORT ON FORM 10-Q

                               Quarter Ended July 31, 1997


                                                                        PAGE
                                                                        ----  

        Part I - Financial Information

           Item 1.  Consolidated Financial Statements:

                    Statement of Earnings for the three months
                    ended July 31, 1997 and 1996                          2

                    Balance Sheet at July 31, 1997 and April 30, 1997     3 

                    Statement of Cash Flows for the three months
                    ended July 31, 1997 and 1996                          4

                    Notes to Financial Statements                         5

                    Independent Accountants' Report                       7

           Item 2.  Management's Discussion and Analysis of 
                    Financial Condition and Results of Operations         8


        Part II - Other Information

           Item 1.  Legal Proceedings                                    11

           Item 5.  Other Information                                    11

           Item 6.  Exhibits and Reports on Form 8-K                     11


        Signature                                                        12


        Exhibit Index                                                    13

<PAGE>4

                        GERBER SCIENTIFIC, INC. AND SUBSIDIARIES
                           CONSOLIDATED STATEMENT OF EARNINGS


                          
                                                            In Thousands 
                                                    (except per share amounts)  
       ------------------------------------------------------------------------
       Three Months Ended July 31,                       1997            1996
       ------------------------------------------------------------------------
       Revenue:

          Product sales                               $  87,410       $  74,530 
          Service                                        11,551          11,278
                                                      ---------       --------- 
                                                         98,961          85,808 
                                                      ---------       ---------

       Costs and Expenses:

          Cost of product sales                          48,088          42,185 

          Cost of service                                 7,817           6,957 

          Selling, general and administrative            30,943          28,595 

          Research and development expenses               7,588           6,776 
                                                      ---------       ---------
                                                         94,436          84,513
                                                      ---------       ---------

       Operating income                                   4,525           1,295 

       Other income                                       2,340             998 
       Interest expense                                     (94)            (90)
                                                      ---------       ---------
       Earnings before income taxes                       6,771           2,203

       Provision for income taxes                         2,200             600 
                                                      ---------       ---------
       Net earnings                                   $   4,571       $   1,603
                                                      =========       ========= 


       Net earnings per common share                  $     .19       $     .07
                                                      =========       =========
       Dividends paid per common share                $     .08       $     .08
                                                      =========       =========
       Average common shares outstanding                 23,714          23,373
                                                      =========       =========


                                 See Accompanying Notes


                                           -2-
<PAGE>5

                         GERBER SCIENTIFIC, INC. AND SUBSIDIARIES
                                CONSOLIDATED BALANCE SHEET
                                                                               
                                                              In Thousands     
       ------------------------------------------------------------------------
                                                        July 31,      April 30,
                                                          1997          1997    
       ------------------------------------------------------------------------
                                          ASSETS

       Current Assets:
         Cash and short-term cash investments          $   16,204    $    9,503
         Accounts receivable                               92,552        92,378
         Inventories                                       64,671        62,221
         Prepaid expenses                                  12,580        13,702
                                                       ----------    ----------
                                                          186,007       177,804
                                                       ----------    ----------

       Investments and long-term 
         receivables                                       35,122        37,037
                                                       ----------    ----------

       Property, plant and equipment                      123,790       121,447
         Less accumulated depreciation                     60,179        58,883
                                                       ----------    ----------
                                                           63,611        62,564
                                                       ----------    ----------

       Intangible assets                                   56,869        56,687
         Less accumulated amortization                     11,163        10,774
                                                       ----------    ----------
                                                           45,706        45,913
                                                       ----------    ----------
       Other assets                                         1,833         1,897
                                                       ----------    ----------
                                                       $  332,279    $  325,215
                                                       ==========    ==========

                           LIABILITIES AND SHAREHOLDERS' EQUITY

       Current Liabilities:
         Notes payable                                 $       --    $       --
         Current maturities of long-term debt                 193           193
         Accounts payable                                  20,782        17,453
         Accrued compensation and benefits                 13,274        14,038
         Other accrued liabilities                         19,711        18,458
         Deferred revenue and litigation award              5,616         6,249
         Advances on sales contracts                        4,154         2,465
                                                       ----------    ----------
                                                           63,730        58,856
                                                       ----------    ----------

       Noncurrent Liabilities:
         Deferred income taxes                             11,271        11,193
         Long-term debt                                     7,098         7,145
                                                       ----------    ----------
                                                           18,369        18,338
                                                       ----------    ----------

       Contingencies and Commitments

       Shareholders' Equity:
         Preferred stock, no par value; authorized
           10,000,000 shares; no shares issued                 --            --
         Common stock, $1.00 par value; authorized
           65,000,000 shares; issued and outstanding 
           23,347,275 and 23,306,900 shares                23,347        23,307
         Paid-in capital                                   36,506        36,100
         Retained earnings                                190,584       187,880
         Cumulative translation component                    (257)          734 
                                                       ----------    ----------
                                                          250,180       248,021
                                                       ----------    ----------
                                                       $  332,279    $  325,215
                                                       ==========    ==========


                                  See Accompanying Notes

                                           -3-

<PAGE>6
                         GERBER SCIENTIFIC, INC. AND SUBSIDIARIES
                           CONSOLIDATED STATEMENT OF CASH FLOWS

                                                                In Thousands
       ------------------------------------------------------------------------
       Three Months Ended July 31,                           1997        1996
       ------------------------------------------------------------------------
       CASH PROVIDED BY (USED FOR):

       Operating Activities
         Net earnings                                     $  4,571    $   1,603
         Adjustments to reconcile net earnings to
           cash provided by operating activities:
             Depreciation and amortization                   3,228        2,931
             Deferred income taxes                              78          905 
             Changes in operating accounts:
               Receivables                                     (67)      (1,483)
               Inventories                                  (2,450)        (977)
               Prepaid expenses                              1,122       (1,539)
               Accounts payable and accrued expenses         4,874       (5,548)
                                                          --------    ---------
       Provided by (Used for) Operating Activities          11,356       (4,108)
                                                          --------    ---------
       Financing Activities
         Repayments of long-term debt                          (47)         (48)
         Exercise of stock options                             446          243
         Dividends on common stock                          (1,867)      (1,855)
                                                          --------    ---------
       Provided by (Used for) Financing Activities          (1,468)      (1,660)
                                                          --------    ---------
       Investing Activities
         Long-term debt securities                           1,808        6,796 
         Additions to property, plant and equipment         (3,765)      (3,180)
         Intangible and other assets                          (239)          62 
         Other long-term investments                          (991)         165 
                                                          --------    ---------
       Provided by (Used for) Investing Activities          (3,187)       3,843
                                                          --------    ---------
       Increase (Decrease) in Cash and Short-Term
         Cash Investments                                    6,701       (1,925)

       Cash and Short-Term Cash Investments,
         Beginning of Period                                 9,503        8,704
                                                          --------    ---------
       Cash and Short-Term Cash Investments, 
         End of Period                                    $ 16,204    $   6,779
                                                          ========    =========

                                  See Accompanying Notes




                                           -4-
<PAGE>7


                        GERBER SCIENTIFIC, INC. AND SUBSIDIARIES
                       NOTES TO CONSOLIDATED FINANCIAL STATEMENTS


          NOTE 1

          The  consolidated   balance  sheet  at   July  31,   1997  and   the
          consolidated statements  of earnings and cash  flows for the  three-
          month periods  ended July 31,  1997 and 1996  are unaudited but,  in
          the  opinion of  the Company,  include all  adjustments,  consisting
          only of normal  recurring accruals, necessary  for a  fair statement
          of the results for the  interim periods.  The  results of operations
          for the three-month period ended July  31, 1997 are not  necessarily
          indicative of the results to be expected for the full fiscal year.

          NOTE 2

          The classification of inventories was as follows (in thousands):

                                      July 31, 1997       April 30, 1997 
                                      -------------       --------------
             Raw materials and
               purchased parts          $ 48,430             $ 49,461
             Work in process              16,241               12,760
                                        --------             --------
                                        $ 64,671             $ 62,221
                                        ========             ========

          NOTE 3

          Net earnings per  common share were calculated  on the basis of  the
          weighted average number of shares of  common stock and common  stock
          equivalents outstanding during each period.

          NOTE 4

          Included in other income  for the three month period ended July  31,
          1997  was  a  gain  resulting  from  the  final  settlement  of  the
          Company's  UK  patent  litigation  with  Lectra  Systemes,  S.A.  of
          France,  which added $1,563,000  to earnings before income taxes and
          approximately $1,000,000, or $.04 per share, to net income.

          NOTE 5

          Subsequent to  the end of the  first quarter,  the Company purchased
          800,000 shares of  its common  stock from  the estate  of H.  Joseph
          Gerber  for  a total  of  $16,400,000, or  $20.50  per  share.   The
          reacquired shares  will be  held by  the Company  as authorized  but
          unissued shares.





                                           -5-

<PAGE>8


                         GERBER SCIENTIFIC, INC. AND SUBSIDIARIES



                With  respect  to  the unaudited  consolidated  financial
                statements of  Gerber Scientific,  Inc. at July  31, 1997
                and for  the three-month periods ended July  31, 1997 and
                1996, KPMG Peat Marwick  LLP has made a review  (based on
                procedures adopted by the American Institute of Certified
                Public Accountants) and  not an  audit, as  set forth  in
                their separate report dated  August 20, 1997 appearing on
                page 7.   That report does not express an  opinion on the
                interim  unaudited  consolidated  financial  information.
                KPMG Peat Marwick LLP has not carried out any significant
                or additional  audit tests beyond those  which would have
                been  necessary if  their report  had not  been included.
                Accordingly, such  report is not  a "report" or  "part of
                the   Registration  Statement"  within   the  meaning  of
                Sections  7 and 11 of the  Securities Act of 1933 and the
                liability provisions  of Section 11  of such  Act do  not
                apply.




                                           -6-

<PAGE>9



                             INDEPENDENT ACCOUNTANTS' REPORT




            To the Board of Directors and Shareholders of
            Gerber Scientific, Inc.


            We have made a review of the consolidated statements of earnings
            and cash flows of  Gerber Scientific, Inc. and subsidiaries  for
            the three-month periods  ended July  31, 1997 and  1996 and  the
            consolidated balance sheet  as of  July 31,  1997 in  accordance
            with   standards  established  by   the  American  Institute  of
            Certified Public  Accountants.   We have previously  audited, in
            accordance  with  generally  accepted  auditing  standards,  and
            expressed  our unqualified  opinion dated  May 22,  1997 on  the
            consolidated   financial   statements   for   the   year   ended
            April 30, 1997  (not  presented  herein).    The  aforementioned
            financial  statements are  the responsibility  of  the Company's
            management.

            A review  of interim financial  information consists principally
            of applying analytical review  procedures to financial data, and
            making  inquiries  of  persons  responsible  for  financial  and
            accounting matters.  It  is substantially less in scope  than an
            examination  in  accordance  with  generally  accepted  auditing
            standards,  the objective  of  which  is  the expression  of  an
            opinion  regarding the  financial statements  taken as  a whole.
            Accordingly, we do not express such an opinion.

            Based   on  our  review,  we  are  not  aware  of  any  material
            modifications   that   should  be   made  to   the  accompanying
            consolidated  statements  of earnings  and  cash  flows for  the
            three-month  periods  ended  July  31, 1997  and  1996,  or  the
            consolidated balance sheet as of July 31, 1997 for them to be in
            conformity with generally accepted accounting principles.  Also,
            in our opinion the  information in the accompanying consolidated
            balance sheet  as of April 30, 1997  is fairly presented, in all
            material respects, in relation to the consolidated balance sheet
            from which it has been derived. 




            /s/ KPMG PEAT MARWICK LLP


            Hartford, Connecticut
            August 20, 1997



                                           -7-

<PAGE>10

                       GERBER SCIENTIFIC, INC. AND SUBSIDIARIES
                       MANAGEMENT'S DISCUSSION AND ANALYSIS OF

                    FINANCIAL CONDITION AND RESULTS OF OPERATIONS


          FINANCIAL CONDITION

          The Company's  ratio of current assets to current liabilities was
          2.9 to 1 at July 31, 1997 compared with 3 to 1 at April 30, 1997.
          Net  working  capital at  July 31,  1997  was $122.3  million, an
          increase of $3.4 million from the beginning of the current fiscal
          year.   The  Company's cash  and short-term  investments totalled
          $16.2 million at July 31, 1997 compared with  $9.5 million at the
          end of the year.  In addition, the Company's investment portfolio
          of  longer-term debt  securities, primarily  tax-exempt municipal
          bonds, totalled  $34.8 million  at  July 31,  1997 compared  with
          $36.6 million  at April 30, 1997.   Subsequent to the  end of the
          first quarter, the Company purchased 800,000 shares of its common
          stock from  the estate of H.  Joseph Gerber for a  total of $16.4
          million,   which  reduced   the   Company's  combined   cash  and
          investments position from $51 million to $34.6 million.

          Operating activities  provided $11.4  million in cash  during the
          first quarter of the current year, a significant improvement from
          use  of $4.1 million of cash in  last year's first quarter.  Cash
          generated by  earnings and the non-cash  charges for depreciation
          and amortization was somewhat offset  by growth in inventories in
          this  year's  first  quarter.   However,  increases  in  accounts
          payable  related to  the  timing of  vendor  payments and  higher
          accrued  liabilities at  July 31,  1997 produced  additional cash
          from operations in this year's first quarter.

          The  principal non-operating uses  of cash  in the  first quarter
          ended  July 31,  1997  were  additions  to property,  plant,  and
          equipment  of  $3.8  million and  payment  of  dividends  of $1.9
          million.  The Company  anticipates that capital  expenditures for
          the current fiscal year  will be in the range  of $11-$13 million
          and  expects  to fund  these  with  cash on  hand  and cash  from
          operations.  
                               
          The Company's total debt at July 31, 1997 was  $7.3 million, down
          slightly  from  April  30, 1997.    The ratio  of  total  debt to
          shareholders' equity  was 2.9 percent at July  31, 1997, compared
          with 3 percent  at April 30, 1997.  The  Company believes its low
          ratio of debt-to-equity is an  important indicator of its ability
          to borrow funds should needs arise.  




                                          -8-

<PAGE>11


          RESULTS OF OPERATIONS

          Combined sales  and service  revenue for  the three  months ended
          July 31, 1997 increased  $13.2 million, or  15 percent, from  the
          first quarter  of  last  year.   The  increase  reflected  higher
          product sales and slightly higher service revenue.  Product sales
          increased in all of  the Company's major product classes  and was
          most significant in  sales of the Company's  GERBERcutter  fabric
          cutting systems.  In addition,  GGT Cutting Edge, an  acquisition
          in last year's  fourth quarter, contributed  $2.8 million of  the
          year-to-year sales  increase.  Sales of  aftermarket supplies for
          the Company's signmaking and graphic  arts systems were higher in
          this  year's first quarter as were sales of the Company's optical
          lens manufacturing  systems  for optical  superstore  chains  and
          wholesale optical laboratories.

          The consolidated gross profit margin in this year's first quarter
          was  43.5 percent compared with  42.7 percent in  the same period
          last  year. Gross profit margins on product sales were 45 percent
          in this  year's first  quarter compared  with  43.4 percent  last
          year.    The  higher  product  margin  this  year  reflected  the
          favorable  effects of  increased  sales volume  in the  Company's
          apparel  manufacturing equipment  and optical  lens manufacturing
          equipment.   An offset to this  margin gain were  higher sales of
          OEM-supplied equipment  for the  electronics  industry and  price
          discounting on computer-to-plate digital imaging  systems for the
          commercial printing  market.   Service gross profit  margins were
          32.3 percent  in this  year's  first quarter  compared with  38.3
          percent  in the prior year.   This decrease  was caused partly by
          costs  in the  current  year associated  with  development of  an
          applications  training revenue  stream from  the printed  circuit
          board and  computer-to-plate systems  businesses.   In  addition,
          service  margins  were  favorably   impacted  last  year  by  the
          utilization of service personnel on a product retrofit program.

          Selling,  general, and  administrative  expenses  in this  year's
          first quarter rose by $2.3 million from last year but declined as
          a  percentage  of revenue  to 31.3  percent  this year  from 33.3
          percent in  last year's  first quarter.   The  increased expenses
          were  caused  primarily by  higher marketing  expenses associated
          with the promotion of new products  and also by the inclusion  of
          the expenses  of GGT  Cutting Edge.   Partially offsetting  these
          increases was the  effect of a cost reduction program implemented
          at the Company's Gerber Garment Technology (GGT) subsidiary.



                                         -9-
<PAGE>12


          The Company continued to commit significant resources to research
          and  the development of new products.  R&D expense increased $0.8
          million  to $7.6 million in  this year's first  quarter from $6.8
          million  last year.  The increase was caused predominantly by the
          development  of new signmaking plotters and  the inclusion of GGT
          Cutting Edge.  The proportion of R&D expenses to sales revenue is
          lower  in this  year's first  quarter at  7.7 percent  versus 7.9
          percent a year earlier.  Management anticipates that this ratio of
          R&D to  revenue will continue to be lower in the current year due
          in part to comparatively lower levels of development spending  in
          computer-to-plate imaging systems for the printing industry.  

          Other income in this year's first quarter was $1.3 million higher
          than  last  year  and  reflected  the  final  settlement  of  the
          Company's  UK  patent litigation  with  Lectra  Systemes S.A.  of
          France,  amounting to  $1.6 million.   After  income  taxes, this
          settlement  amounted  to approximately  $1  million  or $.04  per
          share.   Lower interest income this year resulting from a smaller
          investment  portfolio of  tax-exempt  municipal  bonds  partially
          offset this gain.

          The provision rate for income taxes was 32.5 percent in the first
          quarter  of this year compared  with 27.2 percent  in last year's
          first quarter.   The effective  income tax rate  continued to  be
          lower  than  the 35  percent  statutory  U.S.  Federal  tax  rate
          primarily  because  of tax-exempt  interest  income  and the  tax
          benefits of the Company's Foreign  Sales Corporation.  The  year-
          to-year  increase  in the  provision  rate  reflected the  higher
          marginal combined  Federal and state income  tax rates associated
          with higher levels of pre-tax earnings.

          As a result of the aforementioned, net earnings increased in this
          year's first quarter  to $4.6  million from $1.6  million in  the
          same  period  last year.  Earnings per  share  were $.19  in this
          year's  first quarter,  which included  $.04 per  share from  the
          patent litigation  settlement, compared with $.07  per share last
          year.

          FORWARD LOOKING STATEMENTS

          This report includes forward-looking statements that describe the
          Company's  business  prospects.    Readers should  keep  in  mind
          factors that  could have  an adverse  impact on those  prospects.
          These include  political, economic, or other  conditions, such as
          recessionary  or  expansive  trends,  inflation  rates,  currency
          exchange  rates, taxes  and  regulations and  laws affecting  the
          business, as  well as product competition, pricing, the degree of
          acceptance of new products to the marketplace, and the difficulty
          of forecasting sales at various times in various markets.




                                           -10-

<PAGE>13


                             PART II - OTHER INFORMATION

          Item 1.  Legal Proceedings

                   In  July 1997, the highest  court in the  United Kingdom
                   denied the  Company's  petition  to appeal  the  earlier
                   decision of  the Court  of Appeals relating  to Gerber's
                   patent infringement  suit against  Lectra Systemes, S.A.
                   of France and its UK subsidiary  (Lectra).  The December
                   1996  Court of  Appeals  decision, which  is  now final,
                   required the Company to pay back to Lectra approximately
                   $3.1 million of the original award of approximately $5.9
                   million.  The  gain associated with the  final award was
                   recorded  in other  income  for the  three  month period
                   ended July 31, 1997 and added approximately $1.6 million
                   to  earnings  before income  taxes and  approximately $1
                   million, or $.04 per share, to net income.

          Item 5.  Other Information

                   On August  6, 1997, the  Company issued a  press release
                   reporting the retirement of  Ronald B. Webster, a Senior
                   Vice  President  of the  Company  and  President of  its
                   wholly     owned    subsidiary,     Gerber    Scientific
                   Products(GSP), as of May 1, 1998.  Charles M. Hevenor, a
                   28-year employee of the Company and most recently Senior
                   Vice  President,  Software  and   Systems  of  GSP   was
                   appointed Executive Vice  President and General  Manager
                   of  GSP and  will  become  President  of  GSP  upon  Mr.
                   Webster's retirement next May.

                   On  August 14, 1997, the Company  issued a press release
                   reporting the  purchase of 800,000 shares  of its common
                   stock from the estate of H. Joseph Gerber for a total of
                   $16,400,000,  or  $20.50  per  share.    The  reacquired
                   shares,  which  represented  approximately  3.4%  of the
                   Company's outstanding stock, will be held by the Company
                   as authorized but unissued shares.

          Item 6.  Exhibits and Reports on Form 8-K

          (a)    Exhibits

                 (11)    Statement  regarding  computation  of  per   share
                         earnings.


                 (15)    Letter  regarding   unaudited  interim   financial
                         information.

                 (27)    Financial data schedule.

          (b)    Reports on Form 8-K

                 No Form  8-K was filed  during the quarter  for which this
                 report is filed.

                                           -11-

<PAGE>14


                                       SIGNATURE



            Pursuant to the requirements of the Securities Exchange Act  of
            1934, the Registrant has duly  caused this report to  be signed
            on its behalf by the undersigned, thereunto duly authorized.




                                            GERBER SCIENTIFIC, INC.
                                            -----------------------
                                                  (Registrant)





            Date:  August 28, 1997     By:  /s/ Gary K. Bennett 
                  -----------------         ------------------------------
                                            Gary K. Bennett
                                            Senior Vice President, Finance
                                            and Principal Financial Officer




                                           -12-

<PAGE>15


                                      EXHIBIT INDEX




            Exhibit Index
               Number                  Exhibit                        Page
            -------------              -------                        ----

                 11            Statement Regarding Computation 
                               of Per Share Earnings.*                16      
                         

                 15            Letter Regarding Unaudited Interim
                               Financial Information.*                17


                 27            Financial Data Schedule.*              18





            *Filed herewith.






                                         -13-

<PAGE>16



                                                            EXHIBIT NO. 11 




                              
                         GERBER SCIENTIFIC, INC. AND SUBSIDIARIES

                             COMPUTATION OF PER SHARE EARNINGS



          Three Months Ended July 31,                  1997            1996
          ---------------------------------------------------------------------



          Net earnings                              $ 4,571,000     $ 1,603,000
                                                    ===========     ===========



          Weighted average shares of common
            stock outstanding during the
            period                                   23,326,588      23,210,514



          Common stock equivalents:
           
            Common stock attributable to 
            stock options (treasury stock
            method)                                     387,623         162,504
                                                    -----------     -----------



          Average common shares outstanding          23,714,211      23,373,018
                                                    ===========     ===========



          Net earnings per common share             $       .19     $       .07
                                                    ===========     ===========



          Note: Net earnings per common share as calculated above is presented
                on a primary and fully diluted basis.



                                           -14-

<PAGE>17


                                                             EXHIBIT NO. 15




          To the Board of Directors and Shareholders of
          Gerber Scientific, Inc.


                     
                        Re:  Registration Statements on Form S-8, 
                             File No. 2-93695, No. 33-58668, and
                             No. 333-26177

                             Registration Statement on Form S-3,
                             File No. 33-58670



          With  respect  to   the  subject   Registration  Statements,   we
          acknowledge  our awareness of the use therein of our report dated
          August 20, 1997  related  to  our  review  of  interim  financial
          information.

          Pursuant to  Rule 436(c) under  the Securities Act,  such reports
          are not considered a part of a Registration Statement prepared or
          certified by an accountant  or a report prepared or  certified by
          an accountant within the meaning of Sections 7 and 11 of the Act.


                                          Very truly yours,


                                          /s/ KPMG PEAT MARWICK LLP






          Hartford, Connecticut
          August 20, 1997




                                         -15-